RGEN FY 2015 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena

RGENRepligen Corporation

$7B

FY 2015 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$84M+31.5% YoY

Gross Profit

$48M57.8% margin

Operating Income

$14M16.5% margin

Net Income

$9M11.2% margin

EPS (Diluted)

$0.28

Cash Flow

Operating Cash Flow

$15M

Free Cash Flow

$12M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$146M

Total Liabilities

$23M

Stockholders' Equity

$123M

Cash & Equivalents

$73M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$84M	$64M	+31.5%
Gross Profit	$48M	$36M	+35.9%
Operating Income	$14M	$11M	+28.7%
Net Income	$9M	$8M	+14.4%